Formoterol
Formoterol is an approved active ingredient.
Chemical compound
What it is used for
- Chronic obstructive pulmonary disease
- Asthma
- Obstructive lung disease
- Emphysema
- Chronic bronchitis
- Bronchospasm
Formoterol fumarate inhalation solution is a long-acting beta 2 -adrenergic agonist (beta 2 -agonist) indicated for: • Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD)…
How it works
- Beta-2 adrenergic receptor agonist
Common side effects
Most common adverse reactions ( > 2% and more common than placebo) are diarrhea, nausea, nasopharyngitis, dry mouth, vomiting, dizziness, and insomnia To report SUSPECTED ADVERSE REACTIONS, contact Mylan at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Beta 2 -Agonist Adverse…
Who should not take it
of a LABA, including formoterol fumarate inhalation solution, without an inhaled corticosteroid is contraindicated in patients with asthma.
Pregnancy and breastfeeding
There are limited available data with formoterol fumarate inhalation solution use in pregnant women to inform a drug-associated risk of adverse developmental outcomes.
Brand names
United States
Foradil · Foradil Certihaler · Perforomist
Canada
Oxeze Turbuhaler
Other trade names
Atimos modulite · Oxis · Oxis 12 · Oxis 6 · Performist
Approval status
- US Food and Drug Administration
- prescription · since 2001
- Health Canada
- prescription · marketed
- First approval anywhere
- 2001
Codes
- ATC
- R03AC13, R03CC15
- RxNorm CUI
- 25255
- ChEMBL
- CHEMBL1256786
- PubChem CID
- 3410
- Wikidata
- Q637247
Frequently asked questions
What is Formoterol used for?
Formoterol is used for: Chronic obstructive pulmonary disease, Asthma, Obstructive lung disease, Emphysema, Chronic bronchitis, and Bronchospasm.
What are the brand names of Formoterol?
Brand names of Formoterol include Foradil, Foradil Certihaler, Perforomist, Oxeze Turbuhaler, Atimos modulite, Oxis, Oxis 12, and Oxis 6.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- Health Canada Drug Product Database (Open Government Licence – Canada)